Treatment of Men With Erectile Dysfunction With Transurethral Alprostadil

2021 ◽  
pp. 251-256
Author(s):  
Joshua Bodie
Keyword(s):  
Erectile Dysfunction ◽  
Sexual Intercourse ◽  
Patient Specific ◽  
Initial Experience ◽  
Penile Pain

This chapter summarizes the results of an important trial comparing transurethral alprostadil to placebo in men with erectile dysfunction. Sexual intercourse was reported as having occurred more often in the alprostadil group, and more men in the group experienced orgasm. Penile pain was reported by approximately one-third of men during clinic testing. This study described the initial experience with transurethral alprostadil and identified the effectiveness of patient-specific doses.

Initial experience of low energy shockwaves for the treatment of erectile dysfunction in Teikyo University Hospital, Japan

2011 ◽  
Vol 8 (3) ◽  
pp. 211-211 ◽  
Author(s):  
S.-I. Hisasue ◽  
H. Ide ◽  
T. China ◽  
S. Isotani ◽  
S. Muto ◽  
...  
Keyword(s):  
Erectile Dysfunction ◽  
Low Energy ◽  
University Hospital ◽  
Initial Experience

scholarly journals PENGARUH SINDROMA DEPRESI TERHADAP DISFUNGSI EREKSI

2013 ◽  
Vol 1 (2) ◽  
Author(s):  
Andre Hutagalung ◽  
Christoffel Elim ◽  
Herdy Munayang
Keyword(s):  
Quality Of Life ◽  
Erectile Dysfunction ◽  
Sexual Function ◽  
Key Words ◽  
Sexual Intercourse ◽  
Social Process ◽  
Sexual Life ◽  
Sexual Stimulus ◽  
Physical Diseases

Abstract: Normal sexual function is a bio-psycho-social process which is significantly related to the quality of life (QOL). Any disturbance in one of the components can be a disaster in sexual life.  Erectile dysfunction is a disability to get an erection or to maintain the erection well enough for a sexual intercourse, which persists or recurs at least three months conse-cutively due to either psychogenic or organic disturbances, or both. Some psychogenic dis-turbances especially depression, anxiety, and relational distress, play some important roles in ED. Besides that, aging, low testoteron level, physical diseases, and some certain medicines have to be included. Key words: erection, erectile dysfunction, sexual stimulus, depression.     Abstract: Fungsi seksual yang normal merupakan suatu proses biopsikososial yang berkaitan langsung dengan kualitas hidup. Adanya gangguan pada salah satu komponen dapat menjadi malapetaka bagi kehidupan seksual. Disfungsi ereksi dapat dedefinisikan sebagai suatu keti-dakmampuan untuk ereksi atau mempertahankan ereksi yang cukup untuk melakukan hu-bungan seksual yang memuaskan, yang menetap atau berulang paling tidak selama tiga bulan berturut-turut. Gangguan psikogenik khususnya sindroma depresi, ankietas, dan distres relasional berperan penting dalam hal terjadinya disfungsi ereksi. Disamping itu usia lanjut, rendahnya kadar testoteron, penyakit fisik, dan beberapa jenis obat perlu diperhitungkan. Kata kunci: fisiologi ereksi, disfungsi ereksi, stimulus seksual, depresi.

SU-GG-T-239: Initial Experience of Patient Specific Rotational Quality Assurance for VMAT Using a Cylindrical Diodes Array Detector System

2010 ◽  
Vol 37 (6Part19) ◽  
pp. 3240-3240
Author(s):  
S Qi ◽  
A Hu ◽  
D Westerly ◽  
H Rice ◽  
F Newman ◽  
...  
Keyword(s):  
Quality Assurance ◽  
Detector System ◽  
Patient Specific ◽  
Array Detector ◽  
Initial Experience

scholarly journals Understanding and Managing Erectile Dysfunction in Patients Treated for Cancer

2016 ◽  
Vol 12 (4) ◽  
pp. 297-304 ◽  
Author(s):  
Maria Voznesensky ◽  
Kiran Annam ◽  
Karl J. Kreder
Keyword(s):  
Body Image ◽  
Erectile Dysfunction ◽  
Adverse Effects ◽  
Cancer Treatment ◽  
Hormone Therapy ◽  
Sexual Intercourse ◽  
Erectile Function ◽  
Treatment Options ◽  
Signs And Symptoms ◽  
Patient Age

Cancer can cause sexual adverse effects by direct and indirect pathways. It can involve sexual organs, indirectly affect body image, or cause fatigue or depression with subsequent effects on libido. Erectile dysfunction (ED), the inability to obtain or maintain an erection firm enough for sexual intercourse, can also result from adverse effects of cancer treatment, such as fatigue, pain, or anxiety about therapy. In addition, depressed feelings about having cancer can affect sexuality, causing a range of signs and symptoms that can lead to ED. Chemotherapy, hormone therapy, surgery, and radiation can all cause sexual adverse effects. Additional factors that play a role include patient age and degree of ED before starting cancer treatment. In this article, we discuss how chemotherapy, hormone therapy, surgery, and radiation affect erectile function as well as possible treatment options for ED.

Magnetic Resonance Imaging of Sexual Intercourse: Initial Experience

2001 ◽  
Vol 27 (5) ◽  
pp. 475-482 ◽  
Author(s):  
A. Faix ◽  
J. F. Lapray ◽  
C. Courtieu ◽  
A. Maubon ◽  
Kerry Lanfrey
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Sexual Intercourse ◽  
Initial Experience ◽  
Resonance Imaging

scholarly journals EP-1146: Initial experience with portal dosimetry patient-specific pretreatment verifications of IMRT plans

2013 ◽  
Vol 106 ◽  
pp. S432-S433
Author(s):  
F. Lliso ◽  
M.C. Pujades ◽  
T. Garcia ◽  
J. Gimeno ◽  
V. Carmona ◽  
...  
Keyword(s):  
Patient Specific ◽  
Initial Experience ◽  
Portal Dosimetry

scholarly journals Patient-Specific Simulation of Endovascular Thoracic Aortic Repair: Initial Experience

2017 ◽  
Vol 104 (1) ◽  
pp. 336-341 ◽  
Author(s):  
Liesbeth M. Desender ◽  
Isabelle Van Herzeele ◽  
Zoran Rancic ◽  
Colin Bicknell ◽  
Ignatios Zairis ◽  
...  
Keyword(s):  
Patient Specific ◽  
Initial Experience ◽  
Aortic Repair

Topical alprostadil (Vitaros©) in the treatment of erectile dysfunction after non-nerve-sparing robot-assisted radical prostatectomy

2017 ◽  
Vol 85 (2) ◽  
pp. 55-59 ◽  
Author(s):  
Pier Andrea Della Camera ◽  
Simone Morselli ◽  
Gianmartin Cito ◽  
Giovanni Tasso ◽  
Nicola Laruccia ◽  
...  
Keyword(s):  
Erectile Dysfunction ◽  
Radical Prostatectomy ◽  
Sexual Intercourse ◽  
Performance Status ◽  
Eastern Cooperative Oncology Group ◽  
Nerve Sparing ◽  
Robot Assisted ◽  
Ecog Performance Status ◽  
Comorbidity Index

Objective: The aim of the study is the evaluation of the efficacy and safety of the treatment with topical alprostadil (Vitaros©) in post-robot assisted radical prostatectomy (RARP) rehabilitation therapy of patients with erectile dysfunction (ED). Methods: Seventy-four patients were enrolled and underwent non-nerve-sparing RARP. Inclusion criteria: age <75, preoperatively International Index of Erectile Function (IIEF-5) >16, erection hardness score (EHS) ⩾2, weekly sexual intercourse ⩾1, affirmative answers to Sexual Encounter Profile Question (SEP-Q) 2 and SEP-Q3, Charlson Comorbidity Index (CCI) ⩽5, Eastern Cooperative Oncology Group (ECOG) performance status ⩽1, no moderate/severe cardiovascular disease. Results: Vitaros was administered ⩾2 twice a week. At month 6, the IIEF-5 decreased from 20.5 preoperative to 18.1 post-treatment. EHS score decreased from a mean of 3.3 to a mean of 3.0. The quality of life score decreased from an average of 5.1 to 2.3. Weekly sexual intercourse decreased from an average of 2.1 to 1.7. Six patients dropped out; 89.7% patients showed a positive SEP-Q2 and 77.8% a positive SEP-Q3. All patients responded positively to Global Assessment Questions (GAQ)-1 and 97% to GAQ-2. Of all 68 analyzed patients, 13 (17.6%) switched to intracavernous injection therapy. Conclusions: In conclusion, Vitaros may become a viable alternative to common injective therapies in well-selected patients after RARP.

HP-3-2 Percutaneous Angioplasty of Internal Pudendal Arteries for the Treatment of Arteriogenic Erectile Dysfunction. Initial Experience in Six Patients

2020 ◽  
Vol 17 (6) ◽  
pp. S159
Author(s):  
F. Migliorini ◽  
A. Marcer ◽  
M.F. Lorenzo Gomez ◽  
F. Ribichini ◽  
A.B. Porcaro ◽  
...  
Keyword(s):  
Erectile Dysfunction ◽  
Initial Experience ◽  
Percutaneous Angioplasty
Sign in / Sign up

Export Citation Format

Share Document